V. Vilgrain
Hepatology · 2003–2018
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 109 citations into it
Whom V. Vilgrain trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Jordi Bruix1 , 2 (in Hepatology)
Papers from V. Vilgrain's perspective
Ordered by how strongly the researchers V. Vilgrain trusts endorse each paper. Same corpus, a different order for every researcher.
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
- INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
- The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
- Use of archived specimens in evaluation of prognostic and predictive biomarkers. (Journal of the National Cancer Institute)
- Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity (International Journal of Cancer)
- Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
- Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. (Gastroenterology)
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report (The Lancet Oncology)
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study (Cardiovascular and Interventional Radiology)
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data (Hepatology)
Their papers
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018) — 8,228 citations
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. (2017) — 666 citations
- Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. (2003) — 614 citations
- Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial (2003) — 702 citations